Session Details

[1AS-02]【E】Transposons and Hosts: Symbiosis, Evolution, and Prospects

Wed. Dec 3, 2025 9:00 AM - 11:00 AM JST
Wed. Dec 3, 2025 12:00 AM - 2:00 AM UTC
Room 2(Pacifico Yokohama Conference Center 3F, 301)
Organizer: Mikiko Siomi (The University of Tokyo), Yuka Iwasaki (RIKEN)
Transposons have long been thought to account for approximately 40% of the human genome. However, the Telomere-to-Telomere (T2T) Consortium recently revealed that this proportion reaches 53%. This groundbreaking discovery highlights the “peculiar" symbiotic relationship between humans (and other host organisms) and transposons spanning hundreds of millions of years, heralding a new era of transposon research. What is the true purpose of transposons co-existing in the genome? How have we, as hosts, managed to accommodate, control, and even harness their selfish nature for our benefit? Could transposons hold the potential as a novel modality for drug discovery? In this symposium, researchers exploring transposons from diverse perspectives will come together to share cutting-edge insights and engage in discussions with the audience on these fascinating questions.

Introduction

[1AS-02-01]PIWI-piRISC assembly defect underlying infertility: insights from Drosophila and mouse models

○Mikiko C Siomi1 (1. Graduate School of Science The University of Tokyo)
Comment()

[1AS-02-02(1P-009)]Development of L1 Retrotransposon and eccDNA Reporters for Probing cGAS-STING-Mediated Innate Immune Responses

○Herve Dushimyineza1,2, Jiawei Cai3, Tomoichiro Miyoshi4, Makoto T. Hayashi2,5 (1. Graduate School of Biostudies, Kyoto University , 2. IFOM-KU Joint-Research Laboratory, Graduate School of Medicine, Kyoto University , 3. Nutrition & Biomedicine, Graduate School of Science, Technical University of Munich, 4. Laboratory for Retrotransposon Dynamics, RIKEN Center for Integrative Medical Sciences (IMS), 5. Chromosome Instabilities Unit, IFOM ETS, The AIRC Institute of Molecular Oncology)
Comment()

[1AS-02-03]Centromere-targeted integrations of an LTR retrotransposon via CENH3 chromatin in Arabidopsis

○Sayuri Tsukahara1, Alexandros Bousios2, Estela Perez-Roman2, Sota Yamaguchi1, Basile Leduque3, Aimi Nakano1, Matthew Naish4, Akihisa Osakabe1, Atsushi Toyoda5, Hidetaka Ito6, Alejandro Edera3, Sayaka Tominaga1, Juliarni Juliarni1, Kae Kato7, Shoko Oda1, Soichi Inagaki1, Zdravko Lorković8, Kiyotaka Nagaki9, Frédéric Berger8, Akira Kawabe10, Leandro Quadrana3, Ian Henderson4, Tetsuji Kakutani1 (1. The University of Tokyo, 2. University of Sussex, 3. Universite Paris Saclay, 4. University of Cambridge, 5. National Institute of Genetics, Center for Genetic Resource Information, 6. Hokkaido University, 7. National Institute of Genetics, Department of Integrated Genetics, 8. Gregor Mendel Institute (GMI), 9. Okayama University, 10. Kyoto Sangyo University)
Comment()

[1AS-02-04]Understanding the disease risk of human transposons by population genetics

○Shohei Kojima1,2 (1. Keio Univ., 2. RIKEN)
Comment()

[1AS-02-05]Exploring the evolutionary link between CRISPR-Cas and transposons

○Makoto Saito1 (1. RIKEN Pioneering Research Institute)
Comment()

[1AS-02-06]Chasing the jumping genes

○Zhao Zhang1 (1. Duke University)
Comment()

Conclusion